ResearcherTokyo Medical and Dental UniversityNo recent work listed
Yoshiki Murase
Matched on OpenAlex author ID A5017255108. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper
Papers 3
- RRM1 is mediated by histone acetylation through gemcitabine resistance and contributes to invasiveness and ECM remodeling in pancreatic cancer. First author DOI 10.3892/ijo.2023.5499↗
- C646 inhibits G2/M cell cycle-related proteins and potentiates anti-tumor effects in pancreatic cancer. Co-author DOI 10.1038/s41598-021-89530-8↗
- Successful conversion surgery of distal pancreatectomy with celiac axis resection (DP-CAR) with double arterial reconstruction using saphenous vein grafting fo… Co-author DOI 10.1186/s40792-020-01082-7↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hiroaki Ono · 3 shared papers, 2020–2023 · strength 0.37
- Paper RRM1 is mediated by histone acetylation through gemcitabine resistance and contributes to invasiveness and ECM remodeli… DOI 10.3892/ijo.2023.5499↗
- Paper C646 inhibits G2/M cell cycle-related proteins and potentiates anti-tumor effects in pancreatic cancer. DOI 10.1038/s41598-021-89530-8↗
- Paper Successful conversion surgery of distal pancreatectomy with celiac axis resection (DP-CAR) with double arterial reconst… DOI 10.1186/s40792-020-01082-7↗
- Shuichi Watanabe · 3 shared papers, 2020–2023 · strength 0.37
- Paper RRM1 is mediated by histone acetylation through gemcitabine resistance and contributes to invasiveness and ECM remodeli… DOI 10.3892/ijo.2023.5499↗
- Paper C646 inhibits G2/M cell cycle-related proteins and potentiates anti-tumor effects in pancreatic cancer. DOI 10.1038/s41598-021-89530-8↗
- Paper Successful conversion surgery of distal pancreatectomy with celiac axis resection (DP-CAR) with double arterial reconst… DOI 10.1186/s40792-020-01082-7↗
- Kosuke Ogawa · 3 shared papers, 2020–2023 · strength 0.37
- Paper RRM1 is mediated by histone acetylation through gemcitabine resistance and contributes to invasiveness and ECM remodeli… DOI 10.3892/ijo.2023.5499↗
- Paper C646 inhibits G2/M cell cycle-related proteins and potentiates anti-tumor effects in pancreatic cancer. DOI 10.1038/s41598-021-89530-8↗
- Paper Successful conversion surgery of distal pancreatectomy with celiac axis resection (DP-CAR) with double arterial reconst… DOI 10.1186/s40792-020-01082-7↗
- Minoru Tanabe · 3 shared papers, 2020–2023 · strength 0.37
- Paper RRM1 is mediated by histone acetylation through gemcitabine resistance and contributes to invasiveness and ECM remodeli… DOI 10.3892/ijo.2023.5499↗
- Paper C646 inhibits G2/M cell cycle-related proteins and potentiates anti-tumor effects in pancreatic cancer. DOI 10.1038/s41598-021-89530-8↗
- Paper Successful conversion surgery of distal pancreatectomy with celiac axis resection (DP-CAR) with double arterial reconst… DOI 10.1186/s40792-020-01082-7↗
- Shinji Tanaka · 3 shared papers, 2020–2023 · strength 0.37
- Paper RRM1 is mediated by histone acetylation through gemcitabine resistance and contributes to invasiveness and ECM remodeli… DOI 10.3892/ijo.2023.5499↗
- Paper C646 inhibits G2/M cell cycle-related proteins and potentiates anti-tumor effects in pancreatic cancer. DOI 10.1038/s41598-021-89530-8↗
- Paper Successful conversion surgery of distal pancreatectomy with celiac axis resection (DP-CAR) with double arterial reconst… DOI 10.1186/s40792-020-01082-7↗
- Tomotaka Kato · 2 shared papers, 2021–2023 · strength 0.27
- Daisuke Ban · 2 shared papers, 2020–2021 · strength 0.21
- Paper C646 inhibits G2/M cell cycle-related proteins and potentiates anti-tumor effects in pancreatic cancer. DOI 10.1038/s41598-021-89530-8↗
- Paper Successful conversion surgery of distal pancreatectomy with celiac axis resection (DP-CAR) with double arterial reconst… DOI 10.1186/s40792-020-01082-7↗
- Daisuke Asano · 1 shared paper, 2023 · strength 0.16
- Toshiro Ogura · 1 shared paper, 2021 · strength 0.11
- Hiromichi Ito · 1 shared paper, 2021 · strength 0.11
- Aya Maekawa · 1 shared paper, 2020 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.